Brief: Pharmasimple FY Revenue Down At EUR 30.0 Mln
Feb 23 (Reuters) - Pharmasimple SA ALPHS.PA :
* FY REVENUE EUR 30.0 MILLION VERSUS EUR 45.2 MILLION YEAR
AGO
* START OF AN AMBITIOUS TRANSFORMATION PLAN IN 2022 TO
ACCELERATE
GROWTH
* PLANS TO ADAPT ITS BUSINESS MODEL FROM 2022 TOWARDS AN
ONLINE/OFFLINE MIX
* ACQUISITIONS OF PHARMACIES WILL BE MADE ACCORDING TO
OPPORTUNITIES FROM 2022
Source text for Eikon: ID:nACT73336
Further company coverage: ALPHS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months